Lacosamide Tablet, Film Coated
Product Images NDC 50228-193

8 FDA label images from Sciegen Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 50228-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical Structure (Lacosamide 01)
Chemical structure diagram of the active ingredient lacosamide, showing its molecular configuration with labeled atoms and bonds consistent with the drug's chemical composition.*
FDA Label Image

Figure 1 (Lacosamide 02)

Figure 1 (Lacosamide 02)
A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' displaying seizure frequency reduction percentages for placebo and Lacosamide tablets at different doses across three studies. The vertical axis shows seizure reduction percentage, while the horizontal axis categorizes placebo and Lacosamide tablet doses. Lacosamide consistently shows higher median seizure reduction than placebo across all studies and doses, with statistical significance noted.*
FDA Label Image

Figure 2 (Lacosamide 03)

Figure 2 (Lacosamide 03)
A responder rate curve chart showing proportions of patients with improvement or worsening, comparing Lacosamide at doses of 200 mg/day, 400 mg/day, and 600 mg/day to placebo. The x-axis represents percent of patients, and the y-axis shows responder rate ranging from -100% (worsening) to 100% (improvement). Separate curves illustrate treatment response in studies 2, 3, and 4.*
FDA Label Image

Figure 4 (Lacosamide 04)

Figure 4 (Lacosamide 04)
Kaplan-Meier survival analysis graph showing the time to the second PGTC seizure in a clinical study comparing Lacosamide and placebo. The graph plots the proportion of patients remaining seizure-free over time (days) with curves for Lacosamide and placebo groups and includes risk numbers and statistical values such as p-value and hazard ratio.*
FDA Label Image

Lacosamide-50mg-60s (Lacosamide 50mg 60s)

Lacosamide-50mg-60s (Lacosamide 50mg 60s)
Label for Lacosamide Tablets, USP 50 mg, film-coated tablets by ScieGen Pharmaceuticals Inc. The label states each tablet contains 50 mg lacosamide, storage instructions, and medication dispensing guidelines. The package contains 60 tablets and is marked Rx Only. A barcode and the NDC 50228-192-60 are also visible.*
FDA Label Image

Lacosamide-100mg-60s (Lacosamide 100mg 60s)

Lacosamide-100mg-60s (Lacosamide 100mg 60s)
Label for Lacosamide Tablets USP 100 mg, film-coated oral tablets. The label indicates the quantity as 60 tablets and includes storage instructions, dose information, and a barcode. Manufactured by ScieGen Pharmaceuticals Inc, the label also mentions child-resistant packaging and a medication guide website.*
FDA Label Image

Lacosamide-150mg-60s (Lacosamide 150mg 60s)

Lacosamide-150mg-60s (Lacosamide 150mg 60s)
A prescription drug label for Lacosamide Tablets, USP, 150 mg strength, film-coated tablets by ScieGen Pharmaceuticals Inc. The label indicates a 60-tablet package and includes storage instructions, dosage recommendation to read prescribing information, and barcode. It also notes the tablets contain 150 mg of lacosamide each and cautions to dispense medication guides to patients.*
FDA Label Image

Lacosamide-200mg-60s (Lacosamide 200mg 60s)

Lacosamide-200mg-60s (Lacosamide 200mg 60s)
Label for Lacosamide Tablets, USP 200 mg, film-coated tablets for oral use. The label indicates a bottle containing 60 tablets, manufactured by ScieGen Pharmaceuticals Inc. Storage instructions specify 20° to 25°C with permitted excursions, and other standard dispensing information is included along with a barcode and a 'NO VARNISH' note on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.